Cargando…
Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure
The phase 4 observational cohort study assessed the effectiveness and safety of the thrombopoietin receptor agonist avatrombopag in patients with chronic liver disease (CLD) and thrombocytopenia undergoing a procedure. Patients with CLD may have thrombocytopenia, increasing the risk of periprocedura...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553023/ https://www.ncbi.nlm.nih.gov/pubmed/37800793 http://dx.doi.org/10.1097/MD.0000000000035208 |